Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer(NSCLC)

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 22, 2019

Primary Completion Date

June 25, 2021

Study Completion Date

August 10, 2021

Conditions
Advanced Non-small Cell Lung Cancer
Interventions
DRUG

utidelone injection

utidelone monotherapy in patients with advanced NSCLC by utidelone

Trial Locations (4)

100021

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

150081

Harbin Medical University Cancer Hospital, Harbin

Unknown

Peking Union Hospital, Beijing

Tianjin People's Hospital, Tianjin

All Listed Sponsors
collaborator

Chengdu Biostar Pharmaceuticals

INDUSTRY

lead

Beijing Biostar Pharmaceuticals Co., Ltd.

INDUSTRY